Review: taking Risperidone and Hydroxyzine hydrochloride together


Summary

Drug interactions are reported among people who take Risperidone and Hydroxyzine hydrochloride together. This review analyzes the effectiveness and drug interactions between Risperidone and Hydroxyzine hydrochloride. It is created by eHealthMe based on reports of 801 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Risperidone and Hydroxyzine hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Risperidone

Risperidone has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperidone 13,915 users)

Hydroxyzine Hydrochloride

Hydroxyzine hydrochloride has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. (latest outcomes from Hydroxyzine hydrochloride 1,214 users)

On Jul, 21, 2016

801 people who take Risperidone, Hydroxyzine Hydrochloride are studied.


Number of reports submitted per year:

Risperidone and Hydroxyzine hydrochloride drug interactions.

Drug effectiveness over time:

Risperidone:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Hydroxyzine Hydrochloride:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 16.0% - (1 of 6 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Risperidone:
  • female: 20.0% - (1 of 5 people)
  • male: 0.0% - (0 of 3 people)
Hydroxyzine Hydrochloride:
  • female: 20.0% - (1 of 5 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Risperidone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 3 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Hydroxyzine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 33.0% - (1 of 3 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • drug rash with eosinophilia and systemic symptoms
  • cytomegalovirus infection
  • calciphylaxis
  • cerebral infarction
  • white blood cell count decreased
  • somnolence
  • hypokalaemia
  • pyrexia
  • urinary tract infection
  • ventricular tachycardia
1 - 6 months:
  • hypokalaemia
  • torsade de pointes
  • ventricular tachycardia
  • diabetes mellitus
  • nausea
  • rhabdomyolysis
  • dehydration
  • aggression
  • neuropathy peripheral
  • tachycardia
6 - 12 months:
  • cardiac arrest
  • electrocardiogram qt prolonged
  • type 2 diabetes mellitus
  • pancreatitis
  • diabetic neuropathy
  • dysthymic disorder
  • hypokalaemia
  • muscle spasms
  • nausea
  • suicidal ideation
1 - 2 years:
  • cardiac arrest
  • electrocardiogram qt prolonged
  • type 2 diabetes mellitus
  • paranoia
  • weight increased
  • hyperglycaemia
  • abdominal pain
  • abdominal pain upper
  • anger
  • appendicitis
2 - 5 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • neuropathy peripheral
  • cerebrovascular accident
  • hyperlipidaemia
  • renal failure acute
  • blood cholesterol increased
  • obesity
  • agitation
  • blood triglycerides increased
5 - 10 years:
  • type 2 diabetes mellitus
  • diabetic neuropathy
  • arteriosclerosis coronary artery
  • asthma
  • back pain
  • cellulitis
  • chest pain
  • dementia alzheimer's type
  • hyperkeratosis
  • onychomycosis
10+ years:
  • blood cholesterol increased
  • hyperglycaemia
  • obesity
  • type 2 diabetes mellitus
  • asthma
  • blood triglycerides increased
  • diabetes mellitus
  • diabetic gastroparesis
  • hyperlipidaemia
  • neuropathy peripheral
not specified:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • depression
  • back pain
  • dyspnoea
  • suicidal ideation
  • anxiety
  • insomnia
  • nausea
  • arthralgia

Most common drug interactions by gender *:

female:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • depression
  • back pain
  • nausea
  • suicidal ideation
  • dyspnoea
  • urinary tract infection
  • dizziness
  • headache
male:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • dehydration
  • cytolytic hepatitis
  • aggression
  • agitation
  • tachycardia
  • rhabdomyolysis
  • electrocardiogram qt prolonged
  • drug rash with eosinophilia and systemic symptoms

Most common drug interactions by age *:

0-1:
  • maternal drugs affecting foetus
  • apathy
  • asthenia
  • back pain
  • calculus ureteric
  • decreased appetite
  • depression
  • diabetes mellitus
  • diabetes mellitus insulin-dependent
  • hallucination, auditory
2-9:
  • agitation
  • cytolytic hepatitis
  • dehydration
  • dyskinesia
  • hyperthermia
  • renal failure acute
  • rhabdomyolysis
  • tachycardia
  • aggression
  • altered state of consciousness
10-19:
  • drug rash with eosinophilia and systemic symptoms
  • pyrexia
  • abdominal pain
  • tremor
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • bronchopulmonary aspergillosis
  • cystitis haemorrhagic
  • cytolytic hepatitis
  • cytomegalovirus viraemia
20-29:
  • diabetes mellitus
  • back pain
  • neck pain
  • abdominal pain upper
  • sleep apnoea syndrome
  • asthenia
  • drug abuse
  • suicidal ideation
  • urinary tract infection
  • vision blurred
30-39:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • depression
  • arthralgia
  • hypertension
  • anxiety
  • migraine
  • sinusitis
  • bronchitis
  • agitation
40-49:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • hypokalaemia
  • back pain
  • nausea
  • chest pain
  • insomnia
  • depression
  • suicidal ideation
  • dyspnoea
50-59:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • gastrooesophageal reflux disease
  • insomnia
  • neuropathy peripheral
  • pyrexia
  • depression
  • dyspnoea
  • head injury
  • pain in extremity
60+:
  • confusional state
  • malaise
  • electrocardiogram qt prolonged
  • fall
  • cardiac arrest
  • hypotension
  • dehydration
  • disorientation
  • urinary tract infection
  • decreased appetite

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Risperidone and Hydroxyzine hydrochloride?

Can you answer these questions?

More questions for: Risperidone, Hydroxyzine hydrochloride

You may be interested in these reviews

More reviews for: Risperidone, Hydroxyzine hydrochloride

On eHealthMe, Risperidone (risperidone) is often used to treat schizophrenia. Hydroxyzine hydrochloride (hydroxyzine hydrochloride) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.